Psychometric properties of the Hospital Anxiety and Depression Scale (HADS) in individuals with stable chronic obstructive pulmonary disease (COPD): a systematic review

References

• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease [Internet]. Fontana, USA; 2020. Available from: https://goldcopd.org/wp-content/uploads/2019/11/GOLD-2020-REPORT-ver1.0wms.pdf
   Google Scholar
• Anton A, Ratarasarn K. Pulmonary function testing and role of pulmonary rehabilitation in the elderly population with pulmonary diseases. Curr Geriatr Rep. 2016;5(2):117–123.
   Google Scholar
• World Health Organization. The top 10 causes of death [Internet]; 2018 [cited 2022 Mar 21]. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
   Google Scholar
• Maurer J, Rebbapragada V, Borson S, et al. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008;134(4 Suppl.):43S–56S.
   PubMed Web of Science ®Google Scholar
• Willgoss TG, Yohannes AM. Anxiety disorders in patients with COPD: a systematic review. Respir Care. 2013;58(5):858–866.
   PubMed Web of Science ®Google Scholar
• Yohannes AM, Alexopoulos GS. Depression and anxiety in patients with COPD. Eur Respir Rev. 2014;23(133):345–349.
   PubMedGoogle Scholar
• Panagioti M, Scott C, Blakemore A, et al. Overview of the prevalence, impact, and management of depression and anxiety in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2014;9:1289.
   PubMed Web of Science ®Google Scholar
• Eisner MD, Blanc PD, Yelin EH, et al. Influence of anxiety on health outcomes in COPD. Thorax. 2010;65(3):229–234.
   PubMed Web of Science ®Google Scholar
• Zareifopoulos N, Bellou A, Spiropoulou A, et al. Prevalence, contribution to disease burden and management of comorbid depression and anxiety in chronic obstructive pulmonary disease: a narrative review. COPD. 2019;16(5–6):406–417.
   PubMedGoogle Scholar
• Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67(6):361–370.
   PubMed Web of Science ®Google Scholar
• Dowson C, Laing R, Barraclough R, et al. The use of the Hospital Anxiety and Depression Scale (HADS) in patients with chronic obstructive pulmonary disease: a pilot study. N Z Med J. 2001;114(1141):447–449.
   PubMed Web of Science ®Google Scholar
• Olssøn I, Mykletun A, Dahl AA. The Hospital Anxiety and Depression Rating Scale: a cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry. 2005;5(1):1–7.
   PubMedGoogle Scholar
• de Graaff AM, Cuijpers P, Leeflang M, et al. A systematic review and meta-analysis of diagnostic test accuracy studies of self-report screening instruments for common mental disorders in Arabic-speaking adults. Glob Ment Health. 2021;8:e43.
   Web of Science ®Google Scholar
• Wu Y, Levis B, Sun Y, et al. Accuracy of the Hospital Anxiety and Depression Scale Depression Subscale (HADS-D) to screen for major depression: systematic review and individual participant data meta-analysis. BMJ. 2021;373:n972.
   PubMedGoogle Scholar
• Vodermaier A, Millman RD. Accuracy of the Hospital Anxiety and Depression Scale as a screening tool in cancer patients: a systematic review and meta-analysis. Support Care Cancer. 2011;19(12):1899–1908.
   PubMed Web of Science ®Google Scholar
• González-Roz A, Gaalema DE, Pericot-Valverde I, et al. A systematic review of the diagnostic accuracy of depression questionnaires for cardiac populations: implications for cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2019;39(6):354–364.
   PubMed Web of Science ®Google Scholar
• Litster B, Fiest KM, Patten SB, et al. Screening tools for anxiety in people with multiple sclerosis: a systematic review. Int J MS Care. 2016;18(6):273–281.
   PubMedGoogle Scholar
• Larsen CH, Bendstrup E, Neergaard MA. Screening tools for depression and anxiety in patients with chronic obstructive pulmonary disease – a systematic review. COPD J Chronic Obstr Pulm Dis. 2021;18(6):683–689.
   PubMed Web of Science ®Google Scholar
• Prinsen CAC, Mokkink LB, Bouter LM, et al. COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res. 2018;27(5):1147–1157.
   PubMed Web of Science ®Google Scholar
• Terwee CB, Prinsen CAC, Chiarotto A, et al. COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study. Qual Life Res. 2018;27(5):1159–1170.
   PubMed Web of Science ®Google Scholar
• Mokkink LB, De Vet HCW, Prinsen CAC, et al. COSMIN risk of bias checklist for systematic reviews of patient-reported outcome measures. Qual Life Res. 2018;27(5):1171–1179.
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
   PubMed Web of Science ®Google Scholar
• Nikolovski A, Gamgoum L, Deol A, et al. Psychometric properties of the Hospital Anxiety and Depression Scale (HADS) in individuals with chronic obstructive pulmonary disease (COPD): protocol for a systematic review. JMIR Res Protoc. 2022;11(9):e37854.
   PubMed Web of Science ®Google Scholar
• Alsubheen SA, Oliveira A, Habash R, et al. Systematic review of psychometric properties and cross-cultural adaptation of the University of California and Los Angeles loneliness scale in adults. Curr Psychol. 2021;1–15.
   Google Scholar
• Grygiel P, Humenny G, Rebisz S, et al. Validating the Polish adaptation of the 11-item de Jong Gierveld Loneliness Scale. Eur J Psychol Assess. 2013;29(2):129–139.
   Web of Science ®Google Scholar
• Park C, Majeed A, Gill H, et al. The effect of loneliness on distinct health outcomes: a comprehensive review and meta-analysis. Psychiatry Res. 2020;294:113514.
   PubMed Web of Science ®Google Scholar
• Rodríguez‐Blázquez C, Ayala‐García A, Forjaz MJ, et al. Validation of the De Jong Gierveld Loneliness Scale, 6‐item version, in a multiethnic population of Chilean older adults. Australas J Ageing. 2021;40(2):e100–e108.
   PubMed Web of Science ®Google Scholar
• Gut-Gobert C, Cavaillès A, Dixmier A, et al. Women and COPD: do we need more evidence? Eur Respir Rev. 2019;28(151):180055.
   PubMed Web of Science ®Google Scholar
• Gelberg J, McIvor RA. Overcoming gaps in the management of chronic obstructive pulmonary disease in older patients. Drugs Aging. 2010;27(5):367–375.
   PubMed Web of Science ®Google Scholar
• Al‐Gamal E. Testing of the Hospital Anxiety and Depression Scale in patients with chronic obstructive pulmonary disease. Int J Nurs Terminol Knowledge. 2017;28(2):94–99.
   PubMed Web of Science ®Google Scholar
• Albarrati A, Alzahrani M, Alnahdi AH, et al. Psychometric properties of the Arabic version of the anxiety inventory for respiratory disease in patients with COPD. Disabil Rehabil. 2021;44:1–7.
   Web of Science ®Google Scholar
• Baker AM, Holbrook JT, Yohannes AM, et al. Test performance characteristics of the air, GAD-7, and HADS-Anxiety screening questionnaires for anxiety in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2018;15(8):926–934.
   PubMed Web of Science ®Google Scholar
• Bratås O, Grønning K, Forbord T. Psychometric properties of the Hospital Anxiety and Depression Scale and the General Health Questionnaire‐20 in COPD inpatients. Scand J Caring Sci. 2014;28(2):413–420.
   PubMed Web of Science ®Google Scholar
• Cheung G, Patrick C, Sullivan G, et al. Sensitivity and specificity of the Geriatric Anxiety Inventory and the Hospital Anxiety and Depression Scale in the detection of anxiety disorders in older people with chronic obstructive pulmonary disease. Int Psychogeriatr. 2012;24(1):128–136.
   PubMed Web of Science ®Google Scholar
• Hansen H, Beyer N, Frølich A, et al. Inter-day test–retest reproducibility of the CAT, CCQ, HADS and EQ-5D-3L in patients with severe and very severe COPD. Patient Relat Outcome Meas. 2021;12:117.
   PubMed Web of Science ®Google Scholar
• Phan T, Carter O, Adams C, et al. Discriminant validity of the Hospital Anxiety and Depression Scale, Beck Depression Inventory (II) and Beck Anxiety Inventory to confirmed clinical diagnosis of depression and anxiety in patients with chronic obstructive pulmonary disease. Chron Respir Dis. 2016;13(3):220–228.
   PubMed Web of Science ®Google Scholar
• Puhan MA, Frey M, Büchi S, et al. The minimal important difference of the Hospital Anxiety and Depression Scale in patients with chronic obstructive pulmonary disease. Health Qual Life Outcomes. 2008;6(1):46–46.
   PubMedGoogle Scholar
• Smid DE, Franssen FME, Houben-Wilke S, et al. Responsiveness and MCID estimates for CAT, CCQ, and HADS in patients with COPD undergoing pulmonary rehabilitation: a prospective analysis. J Am Med Dir Assoc. 2017;18(1):53–58.
   PubMed Web of Science ®Google Scholar
• Tang W, Wong E, Chiu HFK, et al. Examining item bias in the anxiety subscale of the Hospital Anxiety and Depression Scale in patients with chronic obstructive pulmonary disease. Int J Methods Psychiatr Res. 2008;17(2):104–110.
   PubMed Web of Science ®Google Scholar
• Wynne SC, Patel S, Barker RE, et al. Anxiety and depression in bronchiectasis: response to pulmonary rehabilitation and minimal clinically important difference of the Hospital Anxiety and Depression Scale. Chron Respir Dis. 2020;17:147997312093329.
   Web of Science ®Google Scholar
• Nowak C, Sievi NA, Clarenbach CF, et al. Accuracy of the Hospital Anxiety and Depression Scale for identifying depression in chronic obstructive pulmonary disease patients. Pulm Med. 2014;2014:1–7.
   Google Scholar